Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP904630.RAeKcSyF-D5drImFwkvUuuthn2gP0JSD16VVbMTY1j624130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904630.RAeKcSyF-D5drImFwkvUuuthn2gP0JSD16VVbMTY1j624130_provenance.
• NP705933.RATx7H7FjpeTprzQHGf9e9KjsceFyTZP5KdyxVkYncOLM130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP705933.RATx7H7FjpeTprzQHGf9e9KjsceFyTZP5KdyxVkYncOLM130_provenance.
• NP647512.RAiFxhoaoN0Pk174EjeoHljFkUF60qGtUeTrXV0A4YJts130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP647512.RAiFxhoaoN0Pk174EjeoHljFkUF60qGtUeTrXV0A4YJts130_provenance.
• NP455548.RAG6FguLKMRyuC5reBLIYICxgeGP1L3sOOCu7Ak9YUpuI130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455548.RAG6FguLKMRyuC5reBLIYICxgeGP1L3sOOCu7Ak9YUpuI130_provenance.
• NP327638.RAOm7rKw7fB6q3z2CEDvT1uvQHAn2zdm0wGDeGlbKX9AU130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327638.RAOm7rKw7fB6q3z2CEDvT1uvQHAn2zdm0wGDeGlbKX9AU130_provenance.
• NP375826.RAwAHG0zs9aTKo6yI2FBJ4BR5ttnwf74OxqtHIEVt0dPQ130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375826.RAwAHG0zs9aTKo6yI2FBJ4BR5ttnwf74OxqtHIEVt0dPQ130_provenance.
• NP846970.RAEszx9FfETZvkufXGgzm_dT93gUh0Qog2WZaNLresvjk130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846970.RAEszx9FfETZvkufXGgzm_dT93gUh0Qog2WZaNLresvjk130_provenance.
• NP538282.RA0bSJNaaW4wYzVNj037zi2ADGimKQk5bJpGR0ONE_R2k130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538282.RA0bSJNaaW4wYzVNj037zi2ADGimKQk5bJpGR0ONE_R2k130_provenance.
• NP620411.RA9SWH1EbkY9nLGDU68y1BVTQznUdiJ2FZBSnxOpDXG7A130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620411.RA9SWH1EbkY9nLGDU68y1BVTQznUdiJ2FZBSnxOpDXG7A130_provenance.
• NP817370.RAVmZ5eSXlSLXZOWWuSNp1zgfMW_uN3yspia_tTEx0LdM130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817370.RAVmZ5eSXlSLXZOWWuSNp1zgfMW_uN3yspia_tTEx0LdM130_provenance.
• NP844744.RA7j6ZjK_FA9sjBzfjzR1pzqiRhLkUGf7TLGH5gnjuH14130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844744.RA7j6ZjK_FA9sjBzfjzR1pzqiRhLkUGf7TLGH5gnjuH14130_provenance.
• NP751474.RA1n44ayWih106c6hMf3Jk_pqSY03vERUDjt_3KamSU54130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751474.RA1n44ayWih106c6hMf3Jk_pqSY03vERUDjt_3KamSU54130_provenance.
• NP751475.RA_Wwp6Hfx8iT-rVicSu5ii1o7h5qNG8gFbqaowc9dP-U130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751475.RA_Wwp6Hfx8iT-rVicSu5ii1o7h5qNG8gFbqaowc9dP-U130_provenance.
• NP751476.RA6pjuAsD3B2doDtQaSnfwmBWBHPjIikvdOo_m7RgGX-s130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751476.RA6pjuAsD3B2doDtQaSnfwmBWBHPjIikvdOo_m7RgGX-s130_provenance.
• NP751479.RA2dqaSh_S_M4bWD-g88369sR74OVTeGw6soUd1LsDtUM130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751479.RA2dqaSh_S_M4bWD-g88369sR74OVTeGw6soUd1LsDtUM130_provenance.
• NP751478.RAfgLtWou5DzUBp_QfVp-FUImEYSL9v2s67fU7-XcROaA130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751478.RAfgLtWou5DzUBp_QfVp-FUImEYSL9v2s67fU7-XcROaA130_provenance.
• NP873683.RAHtlWpK0NwhYJlNNiZ1KNW6CdsVbdEBpzKx2JAqxehqc130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873683.RAHtlWpK0NwhYJlNNiZ1KNW6CdsVbdEBpzKx2JAqxehqc130_provenance.
• NP751481.RAK8REyEjZTucrcBeT12olOnvonfX4u3Bxly2D5lTq4Cs130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751481.RAK8REyEjZTucrcBeT12olOnvonfX4u3Bxly2D5lTq4Cs130_provenance.
• NP334157.RAi-OHAwHX3sog5BTNSZHUb3B-NDRMwA3tObzu51QpGhU130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334157.RAi-OHAwHX3sog5BTNSZHUb3B-NDRMwA3tObzu51QpGhU130_provenance.
• NP847909.RAusj50RsUpBbaYaecqOaHYHi-5vVXVepnV6N8oihBm3Y130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847909.RAusj50RsUpBbaYaecqOaHYHi-5vVXVepnV6N8oihBm3Y130_provenance.
• NP751477.RAi1q8ezHdRBGvDEPiR0RtUB1j5_PUq7eNJnRcJiLRwyM130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751477.RAi1q8ezHdRBGvDEPiR0RtUB1j5_PUq7eNJnRcJiLRwyM130_provenance.
• NP751480.RAq1Wq98yzmf0wL80Kgs8YiEVIWIYywPXOHQFkzUb3z2Y130_assertion description "[Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751480.RAq1Wq98yzmf0wL80Kgs8YiEVIWIYywPXOHQFkzUb3z2Y130_provenance.